目的: 研究人工晶体集采对白内障手术患者住院费用的影响。方法: 利用宁波市病案首页数据,采用诊断相关分组分类方法,对比分析白内障手术病例数量排名前10位的医院人工晶体省际联盟集采前后病种费用、患者结构、平均住院日等指标变化。结果: 60岁—80岁白内障手术患者占比近70%,人工晶体集采后住院费用下降7.59%,其中耗材费下降27.79%,医疗服务费、检查检验费、药品费呈不同幅度增加,平均住院日缩短0.32天。结论: 人工晶体集采对病种费用调控成效显现,但不同医院间费用结构差异明显,建议医院在DRG付费背景下加强病种费用管控,将人工晶体纳入国家集采,进一步降低患者费用负担。

Objective: The paper studies the effect of intraocular lens centralized procurement on hospitalization expenses of cataract surgery patients. Methods: According to the first page of medical records in Ningbo City, the changes of disease cost, patient structure, average hospital stay of top 10 hospitals with cataract surgery cases before and after intraocular lens centralized procurement were compared and analyzed. Results: Patients with cataract surgery aged 60-80 years old accounts for nearly 70%. After intraocular lens centralized procurement, the hospitalization expenses decreased by 7.59%, among which the cost of materials decreased by 27.79%. Medical service fees, inspection fees, and drug costs increased by varying degrees, and the average length of stay was shortened by 0.32 days. Conclusions: The effect of intraocular lens centralized procurement on disease cost control is obvious, but the cost structure of different hospitals is significantly different. It is recommended that hospitals strengthen the control of disease cost under the background of DRG payment, incorporate intraocular lens into the national centralized purchase, and further reduce the cost of patients.